FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “2 SEVENTYBIO”, which is offered here for The mark consists of the stylized design of a 7 comprised of a dark elongated upper triangle and a light elongated lower triangle, with the stylized design of the 7 to the right of 2 and to the left of seventybio in stylized lowercase letters. the elongated upper triangle has a rounded point at its upper right, and its lower side is curved inwardly where it interfaces with the lower elongated triangle, which has a rounded point at its upper right. the number 2 and the letters seventy are bolded relative to the letters bio.;pharmaceutical preparations and substances for the treatment of diseases, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and viral vectors for the treatment of diseases, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer;two seven seventy bio;pharmaceutical research and development;.
Its status is currently believed to be active. Its class is unavailable. “2 SEVENTYBIO” is believed to be currently owned by “2seventy bio, Inc.”
| Owner: |
2SEVENTY BIO, INC.
Owner Details |
|---|---|
| Description: |
The mark consists of the stylized design of a 7 comprised of a dark elongated upper triangle and a light elongated lower triangle, with the stylized design of the 7 to the right of 2 and to the left of SEVENTYBIO in stylized lowercase letters. The elongated upper triangle has a rounded point at its upper right, and its lower side is curved inwardly where it interfaces with the lower elongated triangle, which has a rounded point at its upper right. The number 2 and the letters SEVENTY are bolded relative to the letters BIO.;Pharmaceutical preparations and substances for the treatment of diseases, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and viral vectors for the treatment of diseases, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer;TWO SEVEN SEVENTY BIO;Pharmaceutical research and development;
|
| Categories: |